199 related articles for article (PubMed ID: 21807962)
1. Antitumor compound testing in glioblastoma organotypic brain cultures.
Biggs T; Foreman J; Sundstrom L; Regenass U; Lehembre F
J Biomol Screen; 2011 Sep; 16(8):805-17. PubMed ID: 21807962
[TBL] [Abstract][Full Text] [Related]
2. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
3. Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme.
Checa-Chavarria E; Rivero-Buceta E; Sanchez Martos MA; Martinez Navarrete G; Soto-Sánchez C; Botella P; Fernández E
Mol Pharm; 2021 Apr; 18(4):1558-1572. PubMed ID: 33645231
[TBL] [Abstract][Full Text] [Related]
4. Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines.
Mégalizzi V; Decaestecker C; Debeir O; Spiegl-Kreinecker S; Berger W; Lefranc F; Kast RE; Kiss R
Eur J Cancer; 2009 Nov; 45(16):2893-905. PubMed ID: 19679463
[TBL] [Abstract][Full Text] [Related]
5. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
6. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
Tsai NM; Lin SZ; Lee CC; Chen SP; Su HC; Chang WL; Harn HJ
Clin Cancer Res; 2005 May; 11(9):3475-84. PubMed ID: 15867250
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
8. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
Vogel TW; Zhuang Z; Li J; Okamoto H; Furuta M; Lee YS; Zeng W; Oldfield EH; Vortmeyer AO; Weil RJ
Clin Cancer Res; 2005 May; 11(10):3624-32. PubMed ID: 15897557
[TBL] [Abstract][Full Text] [Related]
9. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.
Gomez-Roman N; Stevenson K; Gilmour L; Hamilton G; Chalmers AJ
Neuro Oncol; 2017 Feb; 19(2):229-241. PubMed ID: 27576873
[TBL] [Abstract][Full Text] [Related]
10. The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.
Sliwa M; Markovic D; Gabrusiewicz K; Synowitz M; Glass R; Zawadzka M; Wesolowska A; Kettenmann H; Kaminska B
Brain; 2007 Feb; 130(Pt 2):476-89. PubMed ID: 17107968
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
[TBL] [Abstract][Full Text] [Related]
12. GM3 as a novel growth regulator for human gliomas.
Noll EN; Lin J; Nakatsuji Y; Miller RH; Black PM
Exp Neurol; 2001 Apr; 168(2):300-9. PubMed ID: 11259118
[TBL] [Abstract][Full Text] [Related]
13. From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage.
Noble M; Gutowski N; Bevan K; Engel U; Linskey M; Urenjak J; Bhakoo K; Williams S
Glia; 1995 Nov; 15(3):222-30. PubMed ID: 8586459
[TBL] [Abstract][Full Text] [Related]
14. Development of glioblastoma cell lines expressing red fluorescence for non-invasive live imaging of intracranial tumors.
Verreault M; Strutt D; Masin D; Fink D; Gill R; Bally MB
Anticancer Res; 2011 Jun; 31(6):2161-71. PubMed ID: 21737636
[TBL] [Abstract][Full Text] [Related]
15. Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.
Mourad PD; Farrell L; Stamps LD; Chicoine MR; Silbergeld DL
Surg Neurol; 2005 Jun; 63(6):511-9; discussion 519. PubMed ID: 15936366
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of F90, an epidermal growth factor receptor tyrosine kinase inhibitor, on glioblastoma cell line SHG-44.
Liu FJ; Gui SB; Li CZ; Sun ZL; Zhang YZ
Chin Med J (Engl); 2008 Sep; 121(17):1702-6. PubMed ID: 19024103
[TBL] [Abstract][Full Text] [Related]
17. Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
Xiao W; Zhang R; Sohrabi A; Ehsanipour A; Sun S; Liang J; Walthers CM; Ta L; Nathanson DA; Seidlits SK
Cancer Res; 2018 Mar; 78(5):1358-1370. PubMed ID: 29282221
[TBL] [Abstract][Full Text] [Related]
18. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons.
Civita P; M Leite D; Pilkington GJ
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795330
[TBL] [Abstract][Full Text] [Related]
19. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
Rempel SA; Dudas S; Ge S; Gutiérrez JA
Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).
Elkamhawy A; Viswanath AN; Pae AN; Kim HY; Heo JC; Park WK; Lee CO; Yang H; Kim KH; Nam DH; Seol HJ; Cho H; Roh EJ
Eur J Med Chem; 2015 Oct; 103():210-22. PubMed ID: 26355532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
